Dr. Faber is a proven leader and brings a wealth of experience and capabilities in many significant areas of medical management.
New York, NY (PRWEB) June 29, 2015
Care to Care, LLC has appointed Leonard A. Farber, M.D. as Section Chief of Radiation Oncology, Care to Care.
Dr. Faber will lead the Radiation Oncology Services Program, with a focus on innovations that foster new ways to approach the complexities of treatment through the use of Care to Care’s proprietary evidence based criteria. He will assist Dr. Julian Safir, Care to Care’s Chief Medical Officer, with health outcomes research as well as clinical integration into other programs including Medical Oncology.
"Dr. Faber is a proven leader and brings a wealth of experience and capabilities in many significant areas of medical management," said Dr. Safir. "By looking at the whole health care picture, Care to Care will continue to be a leader in delivering high quality clinical programs that benefit both the payer and the consumer. I am confident Dr. Faber will contribute significantly to our continued accomplishments in the health services arena."
A Board Certified physician in Radiation Oncology, Dr. Farber specializes in adult radiation oncology, with a particular focus on cancers of the prostate, breast, lung, skin, and gastrointestinal and gynecologic malignancies. He has a special interest in High Dose Rate (HDR) brachytherapy for various types of cancers, including breast, skin, and gynecologic malignancies, and intracranial and stereotactic body radiation therapy (SBRT), all in an outpatient setting. He and his center were the first and only facility in Manhattan to introduce a 5-day hypofractionated SBRT program for prostate cancer treatment. He has implemented volumetric arc therapy (VMAT) in the treatment of benign parotid enlargement/hypertrophy, a disfiguring condition affecting a variety of patients, especially within the HIV+ community.
After receiving his B.S. and B.A. at the State University of New York at Binghamton, Dr. Farber pursued his M.D. at the Mt. Sinai School of Medicine in New York. Following an internship in internal medicine at Beth Israel Medical Center in New York, he completed a residency in Radiation Oncology at the Hospital of the University of Pennsylvania in Philadelphia, where he served as Chief Resident. Dr. Farber is a member of the American Society for Therapeutic Radiology and Oncology, the American College of Radiation Oncology, the NY Roentgen Society, the American Brachytherapy Society, the International Society of Gastrointestinal Oncology, the New York Cancer Society, the New York Metropolitan Breast Cancer Group, the New York Head & Neck Society, and several others.
Dr. Farber has served as principal investigator on many clinical trials and has been on the forefront of the HDR treatment for various types of malignant and benign conditions and SBRT for various malignancies and sites.
About Care to Care, LLC
Care to Care, headquartered in New York, has been in operation since 2007. It has been accredited by the Utilization Review Accreditation Committee (URAC) since 2009, having achieved a 100% score during both re-accreditations cycles. Care to Care was founded on a commitment to use evidence based criteria sets that were specifically designed for a prior authorization program aimed at achieving effectiveness in reducing waste while requiring the least amount of effort on the part of the requesting providers. No information is required beyond that which will allow us to approve appropriate use. Because the system is entirely our own, we are able to keep it current, and to customize it to each client’s particular needs and policies. Care to Care provides utilization and network management to government, commercial and self-funded programs.